SPI-1005

DRUG2 trials

Sponsors

Sound Pharmaceuticals, Incorporated

Conditions

CancerHearing LossMeniere's Disease

Phase 1

Study to Evaluate the Safety and Pharmacokinetics of SPI-1005

CompletedNCT01452607

Sound Pharmaceuticals, IncorporatedCancer, Hearing Loss

Start: 2006-05-31End: 2006-08-31Updated: 2016-06-29

Study to Evaluate SPI-1005 in Adults With Meniere's Disease

CompletedNCT02603081

Sound Pharmaceuticals, IncorporatedMeniere's Disease

Start: 2015-12-01End: 2017-08-01Updated: 2026-06-29

Related Papers

The Clinical Drug Ebselen Attenuates Inflammation and Promotes Microbiome Recovery in Mice after Antibiotic Treatment for CDI

Cell Reports Medicine2020-04-0145 citations